ADAR1 Encourages Keros Therapeutics Shareholders to Reconsider Directors Amid Governance Concerns ADAR1 urges Keros Therapeutics shareholders to withhold votes for directors due to governance issues as outlined by ISS recommendations.

ADAR1 Encourages Keros Therapeutics Shareholders to Reconsider Directors Amid Governance Concerns #USA #Austin #Keros_Therapeutics #ISS_Recommendations #ADAR1_Capital

Burford Capital Advocates Shareholder Support Amidst Proxy Controversy with ISS Burford Capital seeks shareholder support for board re-elections, countering ISS recommendations with substantial qualifications of directors.

Burford Capital Advocates Shareholder Support Amidst Proxy Controversy with ISS #United_States #New_York #Proxy_Vote #Burford_Capital #ISS_Recommendations